Press Dossier   News Category    Legal    Saudi Jamjoom Pharma to invest $52m in Uzbekistan as it eyes Central Asia expansion

Arab News, Saturday, Aug 20, 2022 | Muharram 22, 1444

Saudi Jamjoom Pharma to invest $52m in Uzbekistan as it eyes Central Asia expansion

Saudi Arabia: Saudi Arabian pharmaceutical firm Jamjoom Pharma has signed an agreement to invest over $52 million in Uzbekistan, as the firm continues its expansion into the Central Asian region, the company's vice chairman said.

In an exclusive interaction with Arab News on the sidelines of the fourth meeting of the Saudi-Uzbeki Business Council in Jeddah, Mahmoud Jamjoom, vice chairman of Jamjoom Pharma, said that launching its operations in Uzbekistan is a gateway to the region.

“Already, we are in 30-plus countries. Now, we are trying to focus on this area (Central Asia). We are covering Uzbekistan, Afghanistan, and Turkmenistan. So, this will be the gate to cover the area,” said Jamjoom.

He said that the operations in Uzbekistan will begin soon once they receive approvals from regulators.

“We will be submitting the files. We will then start presenting the product in Uzbekistan. And step by step, we will have local manufacturing,” added the vice chairman.

Page 1 Of 1